Release Date: 28/09/10 11:48 Summary: Appendix 3B (Options Exercised) Price Sensitive: No Download Document 49.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%